Health Condition 1: G00-G99- Diseases of the nervous system
Conditions
Interventions
None listed
Sponsors
Vedistry Pvt. Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Subjects with having with symptoms of Migraine one sided throbbing headache /Nausea & vomiting Sensitivity to light & sound more than 3 months Completed the screening process within 3 days prior to randomization Study participant has understood and signed the informed consent form to participate in the study. Study participant willing to be available for the entire study period and adhere to protocol requirements as evidenced by signing the informed consent document
Exclusion criteria
Exclusion criteria: Complicated and special types of gastritis hemorrhage peptic ulcer cholelithiasis cholecystitis, dysplasia of gastric mucosa or pathological diagnosis of suspected malignant change Reports any presence or history of a clinically significant disorder involving the cardiovascular, respiratory, renal, urologic, hepatic, immunologic, endocrine, or neurologic systems or psychiatric disease as determined by the investigator(s). Pregnant and lactating women; Had a history of allergy from trial medication; Subject who has been involved with another experimental trial within the past 30 days from the date of recruitment. Subjects using over-the-counter or prescription anti-reflux agents (Allopathic, Herbal, Homeopathic, Ayurveda, Unani, Siddha medicines) within the past 14 days from the date of recruitment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Reduction in migraine pain intensity over 30 days by a validated pain scale 2.Decrease in the number of migraine episodes per week over 30 days 3.Reduction in the occurrence of nausea, vomiting, photophobia, and phono phobia over 30 days 4.Time to significant relief from acute migraine pain over 30 daysTimepoint: 1 Visit 1 Baseline 2 Visit 2 Day 15 3 Visit 3 Day 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of Migreez Tablet & Drop in chronic migraine patients.Timepoint: 1 Visit 1 Baseline 2 Visit 2 Day 15 3 Visit 3 Day 30 | — |
Countries
India
Contacts
Public ContactDr T vishala
Yashwant Ayurvedic College
Outcome results
None listed